These are the key contradictions discussed in FitLife Brands' latest 2024Q4 earnings call, specifically including: Supply Chain and Tariff Issues, and Future Revenue Expectations:
Revenue and Growth:
- FitLife Brands reported
total revenue of
$64.5 million for the full year 2024, an increase of
22% year-over-year.
- The growth was primarily driven by a
29% increase in online sales and benefited from the integration and optimization of acquired brands.
Legacy FitLife Performance:
- Legacy FitLife revenue for Q4 2024 was
$5.3 million, declining
13% overall, with a
1% decline in online sales.
- The decline was due to a commercial dispute with GNC, leading to a halt in orders andDirect fulfillment to franchisees.
MusclePharm Brand Growth:
- MusclePharm's revenue increased
14% sequentially in Q4 2024, driven by a
37% increase in wholesale revenue.
- Growth was attributed to increased promotional investments and new product launches under the MusclePharm Pro Series.
Mimi's Rock (MRC) Brands Performance:
- MRC revenue for Q4 2024 was
$6.9 million, down slightly
0.4% from the previous year.
- Challenges in the skin care brands and a revenue optimization process led to a decline, but contributed as a percentage of revenue increased from
28.2% to
37.1%.
Comments
No comments yet